Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units
- PMID: 10684911
- DOI: 10.1056/NEJM200002243420802
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units
Abstract
Background: Bacterial vaginosis has been associated with preterm birth. In clinical trials, the treatment of bacterial vaginosis in pregnant women who previously had a preterm delivery reduced the risk of recurrence.
Methods: To determine whether treating women in a general obstetrical population who have asymptomatic bacterial vaginosis (as diagnosed on the basis of vaginal Gram's staining and pH) prevents preterm delivery, we randomly assigned 1953 women who were 16 to less than 24 weeks pregnant to receive two 2-g doses of metronidazole or placebo. The diagnostic studies were repeated and a second treatment was administered to all the women at 24 to less than 30 weeks' gestation. The primary outcome was the rate of delivery before 37 weeks' gestation.
Results: Bacterial vaginosis resolved in 657 of 845 women who had follow-up Gram's staining in the metronidazole group (77.8 percent) and 321 of 859 women in the placebo group (37.4 percent). Data on the time and characteristics of delivery were available for 953 women in the metronidazole group and 966 in the placebo group. Preterm delivery occurred in 116 women in the metronidazole group (12.2 percent) and 121 women in the placebo group (12.5 percent) (relative risk, 1.0; 95 percent confidence interval, 0.8 to 1.2). Treatment did not prevent preterm deliveries that resulted from spontaneous labor (5.1 percent in the metronidazole group vs. 5.7 percent in the placebo group) or spontaneous rupture of the membranes (4.2 percent vs. 3.7 percent), nor did it prevent delivery before 32 weeks (2.3 percent vs. 2.7 percent). Treatment with metronidazole did not reduce the occurrence of preterm labor, intraamniotic or postpartum infections, neonatal sepsis, or admission of the infant to the neonatal intensive care unit.
Conclusions: The treatment of asymptomatic bacterial vaginosis in pregnant women does not reduce the occurrence of preterm delivery or other adverse perinatal outcomes.
Comment in
-
Antibiotics for the prevention of preterm birth.N Engl J Med. 2000 Feb 24;342(8):581-3. doi: 10.1056/NEJM200002243420810. N Engl J Med. 2000. PMID: 10684919 No abstract available.
Summary for patients in
-
Treating asymptomatic bacterial vaginosis in pregnancy.Can Fam Physician. 2002 May;48:891-3. Can Fam Physician. 2002. PMID: 12138871 Free PMC article. No abstract available.
Similar articles
-
Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.N Engl J Med. 1995 Dec 28;333(26):1732-6. doi: 10.1056/NEJM199512283332603. N Engl J Med. 1995. PMID: 7491136 Clinical Trial.
-
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.N Engl J Med. 2001 Aug 16;345(7):487-93. doi: 10.1056/NEJMoa003329. N Engl J Med. 2001. PMID: 11519502 Clinical Trial.
-
A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.BJOG. 2006 Jan;113(1):65-74. doi: 10.1111/j.1471-0528.2005.00788.x. BJOG. 2006. PMID: 16398774 Clinical Trial.
-
What have we learned about vaginal infections and preterm birth?Semin Perinatol. 2003 Jun;27(3):212-6. doi: 10.1016/s0146-0005(03)00020-x. Semin Perinatol. 2003. PMID: 12889588 Review.
-
Bacterial vaginosis and other asymptomatic vaginal infections in pregnancy.Curr Womens Health Rep. 2001 Aug;1(1):14-9. Curr Womens Health Rep. 2001. PMID: 12112946 Review.
Cited by
-
Primary prevention with vaginal chlorhexidine before 16 weeks reduces the incidence of preterm birth: results of the Preterm Labor Prevention Using Vaginal Antiseptics study.AJOG Glob Rep. 2023 Oct 16;3(4):100277. doi: 10.1016/j.xagr.2023.100277. eCollection 2023 Nov. AJOG Glob Rep. 2023. PMID: 38107249 Free PMC article.
-
Routine screening of abnormal vaginal flora during pregnancy reduces the odds of preterm birth: a systematic review and meta-analysis.Sci Rep. 2023 Aug 25;13(1):13897. doi: 10.1038/s41598-023-40993-x. Sci Rep. 2023. PMID: 37626108 Free PMC article.
-
Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for Clinicians.Int J Womens Health. 2023 Aug 9;15:1317-1325. doi: 10.2147/IJWH.S383333. eCollection 2023. Int J Womens Health. 2023. PMID: 37581202 Free PMC article. Review.
-
Effect of vaginal microbiota on pregnancy outcomes of women from Northern China who conceived after IVF.Front Endocrinol (Lausanne). 2023 Jul 18;14:1200002. doi: 10.3389/fendo.2023.1200002. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37547323 Free PMC article.
-
The Effect of Sexual Intercourse during Pregnancy on Preterm Birth: Prospective Single-Center Cohort Study in Japan.Healthcare (Basel). 2023 Jun 5;11(11):1657. doi: 10.3390/healthcare11111657. Healthcare (Basel). 2023. PMID: 37297797 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical